In breast cancer, EGFR overexpression correlates with estrogen receptor loss and poor prognosis, suggesting its role in promoting growth in estrogen receptor-positive breast cancer cells, even in the absence of estrogen. This evidence concerns the gene ESR1 and breast cancer.